DMAb levels remained stable for 72 weeks in all participants (n=24) who have reached that timepointNo anti-drug antibodies (ADA): no immune rejection of the DMAbs was detected across ~1,000 blood ...

At a time when global coordination against health threats is critical, recent policy shifts in the U.S. have created a ...

Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...

The door may now be open for additional challenges to patents covering mRNA vaccine technologies, paving the way for increased competition in the ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

The current vaccines in the market use lipid delivery technology to deliver mRNA to induce ... which is being developed to inhibit viral replication caused by influenza or SARS-CoV-2, and Epoladerm™, ...

Objective This study aimed to establish HAV and HEV infections in multiple small animals by intravenously injecting lipid nanoparticle (LNP)-encapsulated full-length viral RNAs (LNP-vRNA). Design In ...

Various materials, including polymers, lipids, and inorganic substances, can be used to create these nanoparticles, and these materials can be tailored for better drug loading, compatibility with ...

Scientists unlock the potential of fenugreek-based lipid nanoparticles to improve diabetes treatment, offering a promising alternative for enhanced drug delivery and long-term stability.